GlassScriptPhysician profile
Jason Wilson
NPI 1316321730
$2,174.26
in general payments reported to CMS, 2019-2025
11 companies · $496 in 2025
The $496 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $191 · 2021: $86.22 · 2022: $363 · 2023: $507 · 2024: $213 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.99 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $541.13 | 2019-2025 | Precision7, Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $368.03 | 2022-2025 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $243.20 | 2019-2021 | |
| Glaukos Corporation | $235.71 | 2024-2025 | Idosetr, Ce-Marked Kxla System |
| Coopervision INC. | $220.72 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Mallinckrodt Hospital Products INC. | $181.24 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $166.01 | 2022-2023 | Tyrvaya |
| Shire North American Group INC | $85.67 | 2019 | |
| Dompe US, INC. | $62.95 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $57.05 | 2019-2020 | |
| Allergan, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.